Partners in Pathology: A Collaborative Model to Bring Pathology to Resource Poor Settings
Partners in Pathology: A Collaborative Model to Bring Pathology to Resource Poor Settings
复制标题
DOI：
10.1097/pas.0b013e3181c17fe6
复制
发表时间：
2010-01-01
影响因子：
5.6
通讯作者：
Milner, Danny A., Jr.
中科院分区：
文献类型：
--
作者：
Carlson, Joseph W.;Lyon, Evan;Milner, Danny A., Jr.
病理学在病人、医生和可以提供给他们的治疗和手术干预之间提供了一个重要的桥梁。在资源贫乏的环境中照顾病人的临床医生可以提供基本的医疗保健，但不包括获得病理服务；然而，病理学在缓解服务不足患者的健康差异方面的价值在实施时是巨大的。卫生合作伙伴是一个综合性的社区卫生保健组织，在7个国家（大多数是世界上最贫穷的国家）设有诊所，有能力获得手术活检，并在可以做出病理诊断的情况下提供治疗和长期随访。在过去5年中，布里格姆妇女医院的病理学家与卫生合作伙伴的临床医生合作，以满足这一需求，其中包括来自海地和卢旺达的129例病例和一系列病理：64例恶性肿瘤，28例正常组织或非诊断标本，16例感染或炎症病例，8例良性病变和其他罕见实体。通过与现场工作的临床医生合作，在资源贫乏的环境中提供病理服务，只会受到建立工作协作的阻碍；然而，好处是巨大的，包括患者获得治愈或量身定制的治疗，治疗资源的后勤管理，以及病理学家接触独特和具有挑战性的病例。
Pathology provides a critical bridge between the patients, their physicians and the therapeutic and surgical interventions that can be provided to them. Clinicians caring for patients in resource poor settings may provide basic healthcare, which does not include access to pathologic services; however, the value of pathology in alleviating health disparities for Underserved patients is substantial when implemented. Partners in health is a comprehensive, community-based healthcare organization with clinics in 7 countries-most among the poorest in the world-which has the ability to obtain surgical biopsies and, if a pathologic diagnosis can be rendered, provide treatment, and long-term follow-up. Over the past 5 years, pathologists from the Brigham and Women's Hospital have collaborated with clinicians from partners in health to meet this need which included 129 cases from Haiti and Rwanda and a range of pathology: 64 malignancies, 28 normal tissue or nondiagnostic specimens, 16 infectious or inflammatory cases, 8 benign lesions, and other rare entities. Providing pathology services in resource poor settings through collaboration with clinicians working on-site is only hindered by the establishment of a working collaboration; however, the benefits are enormous and include patient access to curative or tailored therapies, logistical management of treatment resources, and exposure of pathologists to unique and challenging cases.